Board of Directors
BIOTECanada is served by a volunteer Board of Directors:
Executive Committee
Brad Thompson, President & CEO, Oncolytics Biotech Inc.(Chair)
Brian Lewis, General Manager, Genzyme Canada Inc. (Treasurer)
Murray McLaughlin, President & CEO, Sustainable Chemistry Alliance
(Member at Large)
Peter Brenders, President & CEO - BIOTECanada (Secretary)
Members
Thomas Bailey,
CFO, Angiotech Pharmaceuticals, Inc.
Jane Clark, Life Sciences Group Leader, Gowling Lafleur Henderson LLP
René Douville, Director, RBC Capital Markets
Michel Fortin, President & CEO, Prevtec Microbia Inc.
Greg Gubitz, Senior Vice President, Corporate Development, Biovail Corporation
Ed Gudaitis, General Manger, Gilead Sciences Canada Inc.
John Helou, General Manager, Pfizer Canada Inc.
Doug Janzen, President & CEO, Cardiome Pharma Corp.
Ron Keefe, President & CEO, Biovectra Inc.
Vince Lamanna, President, Novo Nordisk Canada Inc.
John Langstaff, President & CEO, Cangene Corporation
Mark Lievonen, President, Sanofi Pasteur Limited
Ross MacLachlan, President & CEO, Lignol Energy Corporation
Gordon McCauley, President & CEO, Allon Therapeutics, Inc.
Greg Penner, President & CEO, NeoVentures Biotechnology Inc.
Andy Potter, Director & CEO, VIDO, University of Saskatchewan
Wayne Quigley, President & General Manager, Bristol-Myers Squibb Canada
Yves Rosconi, President & CEO, Theratechnologies Inc.
Andrew Sheldon, President & CEO, Medicago Inc.
Lyndal Walker, Vice President and General Manager, Abraxis BioScience, Canada Inc.
Jim Wispinski, President & CEO, Dow AgroSciences Canada Inc.
